The closing price of Tarsus Pharmaceuticals Inc (NASDAQ: TARS) was $38.22 for the day, up 0.92% from the previous closing price of $37.87. In other words, the price has increased by $+0.35 from its previous closing price. On the day, 463160 shares were traded. TARS stock price reached its highest trading level at $38.89 during the session, while it also had its lowest trading level at $36.95.
Ratios:
Our analysis of TARS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.85 and its Current Ratio is at 6.93. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.16.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on November 20, 2023, initiated with a Neutral rating and assigned the stock a target price of $19.
On July 18, 2023, William Blair started tracking the stock assigning a Outperform rating and target price of $44.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 27 when Azamian Bobak R. sold 8,000 shares for $20.22 per share. The transaction valued at 161,760 led to the insider holds 830,106 shares of the business.
Azamian Bobak R. sold 40,000 shares of TARS for $810,623 on Dec 20. The President/CEO and Board Chair now owns 838,106 shares after completing the transaction at $20.27 per share. On Dec 20, another insider, Trevejo Jose M., who serves as the CHIEF MEDICAL OFFICER of the company, sold 2,252 shares for $20.00 each. As a result, the insider received 45,040 and left with 2,251 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TARS now has a Market Capitalization of 1.30B and an Enterprise Value of 1.10B. For the stock, the TTM Price-to-Sale (P/S) ratio is 72.50 while its Price-to-Book (P/B) ratio in mrq is 6.64. Its current Enterprise Value per Revenue stands at 62.93 whereas that against EBITDA is -8.28.
Stock Price History:
Over the past 52 weeks, TARS has reached a high of $40.40, while it has fallen to a 52-week low of $11.33. The 50-Day Moving Average of the stock is 25.67, while the 200-Day Moving Average is calculated to be 19.22.
Shares Statistics:
TARS traded an average of 782.45K shares per day over the past three months and 1.09M shares per day over the past ten days. A total of 34.21M shares are outstanding, with a floating share count of 24.66M. Insiders hold about 25.52% of the company’s shares, while institutions hold 85.07% stake in the company. Shares short for TARS as of Feb 15, 2024 were 5.66M with a Short Ratio of 7.24, compared to 5.02M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 16.55% and a Short% of Float of 17.42%.
